Estimated Fair Value
Medtronic Estimated Fair Value increased by 2.8% to $7.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $6.70B to $7.26B. Over 3 years (FY 2022 to FY 2025), Estimated Fair Value shows relatively stable performance with a -0.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase relative to amortized cost indicates unrealized gains, while a decrease indicates unrealized losses due to market volatility or interest rate changes.
Detailed definition
The current market value of debt securities classified as available-for-sale, excluding accrued interest. This metric pr...
Peer comparison
Standard for insurers; peers with similar duration profiles will show similar sensitivity to market interest rate changes.
other_debt_securities_available_for_sale_excluding_accru_fbe99dHistorical Data
| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.89B | $6.64B | $6.65B | $6.45B | $6.57B | $6.46B | $6.70B | $6.72B | $6.53B | $6.59B | $6.70B | $6.75B | $6.86B | $7.06B | $7.26B |
| QoQ Change | — | -3.7% | +0.2% | -3.0% | +1.9% | -1.7% | +3.8% | +0.3% | -2.9% | +0.9% | +1.6% | +0.8% | +1.6% | +2.9% | +2.8% |
| YoY Change | — | — | — | -6.4% | — | -2.7% | +0.8% | +4.2% | -0.6% | +2.1% | -0.1% | +0.4% | +5.0% | +7.1% | +8.3% |
Estimated Fair Value at Other Companies
Frequently Asked Questions
- What is Medtronic's estimated fair value?
- Medtronic (MDT) reported estimated fair value of $7.26B in Q4 2025.
- How has Medtronic's estimated fair value changed year-over-year?
- Medtronic's estimated fair value increased by 8.3% year-over-year, from $6.70B to $7.26B.
- What is the long-term trend for Medtronic's estimated fair value?
- Over 3 years (2022 to 2025), Medtronic's estimated fair value has grown at a -0.7% compound annual growth rate (CAGR), from $6.89B to $6.75B.
- What does estimated fair value mean?
- The current market price of the company's available-for-sale debt investments.